Reminder: Invitation to Capital Markets Day 10 May 2023

08. May 2023 | 1 min read

Gentian Diagnostics will host a capital markets day for investors, analysts and media on 10 May 2023 at the company’s headquarter in Bjørnåsveien 5, 1596 Moss, Norway. In-person attendance is encouraged. The presentations from the event will be broadcasted live to participants not able to join in person.

Programme for the day:

12.00-12.30 CEST: Registration and light lunch
12.30-15.00 CEST: Presentations covering the following topics:

  • Introduction – Hilja Ibert CEO
  • R&D review – Torsten Knüttel VP R&D
  • From science to sales: Gentian’s successful journey for established products – Aleksandra Havelka CSO and Markus Jaquemar CCO
  • Strategic roadmap – Njaal Kind CFO

15.00-16.00 CEST: Site visit

Please register your attendance to the capital markets day using the following link: https://share.hsforms.com/1U6UM-O9vRvKJrGQpE0PRaw40qka, or send an e-mail to invest@gentian.no 

IR contact: Njaal Kind, CFO njaal.kind@gentian.no +47 919 06 525 (mobile)

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..